Limosilactobacillus reuteri DSM 17938 supplementation and SARS-CoV-2 specific antibody response in healthy adults: a randomized, triple-blinded, placebo-controlled trial

por Forsgård, Richard A., Rode, Julia, Lobenius-Palmér, Karin, Kamm, Annalena, Patil, Snehal, Tacken, Mirriam G. J., Lentjes, Marleen A. H., Axelsson, Jakob, Grompone, Gianfranco, Montgomery, Scott, Brummer, Robert J.
Publicado 2023